Allison DeAngelis and Andrew Joseph

BioTech

Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion,

Allison DeAngelis and Andrew Joseph January 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Allison DeAngelis and Andrew Joseph

Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe